|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2005-11-24
|
|
pubmed:abstractText |
The primary objectives of this study were to determine the efficacy and tolerability of a pemetrexed-carboplatin combination as first-line therapy in patients with advanced nonsmall cell lung cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
pubmed-author:BlumenscheinGeorge RGRJr,
pubmed-author:CurielRafael ERE,
pubmed-author:FossellaFrank VFV,
pubmed-author:GladishGregory WGW,
pubmed-author:GlissonBonnie SBS,
pubmed-author:HerbstRoy SRS,
pubmed-author:HongWaun KWK,
pubmed-author:KimEdward SES,
pubmed-author:ObasajuColeman KCK,
pubmed-author:OhYun WYW,
pubmed-author:PapadimitrakopoulouVassiliki AVA,
pubmed-author:PeeplesBeverly OBO,
pubmed-author:PistersKatherine M WKM,
pubmed-author:YeZhishenZ,
pubmed-author:ZinnerRalph GRG
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
104
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2449-56
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16258975-Adult,
pubmed-meshheading:16258975-Aged,
pubmed-meshheading:16258975-Antineoplastic Agents,
pubmed-meshheading:16258975-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16258975-Carboplatin,
pubmed-meshheading:16258975-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:16258975-Disease Progression,
pubmed-meshheading:16258975-Female,
pubmed-meshheading:16258975-Follow-Up Studies,
pubmed-meshheading:16258975-Glutamates,
pubmed-meshheading:16258975-Guanine,
pubmed-meshheading:16258975-Humans,
pubmed-meshheading:16258975-Lung Neoplasms,
pubmed-meshheading:16258975-Male,
pubmed-meshheading:16258975-Middle Aged,
pubmed-meshheading:16258975-Patient Selection,
pubmed-meshheading:16258975-Survival Analysis,
pubmed-meshheading:16258975-Time Factors
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancer.
|
|
pubmed:affiliation |
The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. rzinner@mdanderson.org
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
